Nerviano Medical Sciences

The largest pharmaceutical R&D facility in Italy and one of the largest oncology-focused, integrated discovery and development companies in Europe.
Vinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo Slider

Latest News

Dr. Marina Mapelli guest at the Oncology Seminar at Nerviano Medical Sciences On Friday April 20th, at 1.30 PM, Dr. Marina Mapelli from the Institute of European Institute of Oncology in Milano, Italy will present an Oncology Seminar entitled "Inscuteable and NuMa bind competitively to LGN: structure and implications for asymmetric cell divisions" Marina Mapelli received her Degree in Physics in 1995 at the University of Milan and in 2000 she obtained the PhD in... Read more
Dr. Francesco Bertoni guest at the Oncology Seminar at Nerviano Medical Sciences On Friday April 13th, at 1.30 PM, Dr. Francesco Bertoni from the Institute of Oncology Research in Bellinzona, Switzerland, will present an Oncology Seminar entitled "Array-CGH provides insights into the pathogenesis of diffuse large B-cell lymphomas" Francesco Bertoni obtained his degree in Medicine in 1994 at the University of Milan. Afterwards he specialized in Oncology in 1998 in the same... Read more
Nerviano Medical Sciences to present data on novel anticancer molecules at the AACR Annual Meeting 2012 Nerviano, Mar 1, 2012. – Nerviano Medical Sciences will disclose data on novel anticancer molecules at the AACR Annual Meeting 2012.The presentations include:Magnaghi, P et al: “Identification of potent VCP/p97/CDC48 inhibitors with distinct biochemical mechanisms including a reversible, allosteric inhibitor that activates the unfolded protein response, induce autophagy and cancer cell death”.... Read more

Oncology

Nerviano Medical SciencesWe fight cancer. Our mission is to identify innovative agents for clinical development in areas of unmet

Read more...

M.I.O.

Nerviano Medical SciencesM.I.O. operates as your partner in the clinical development and life-cycle management

Read more...

Accelera

AcceleraAccelera is committed to predicting and managing potential toxic, pharmacokinetic

Read more...

NerPharMa / DS

NerpharmaNerPharMa and
NerPharMa DS are leading players in high-containment contract

Read more...